Држава: Јужноафричка Република
Језик: Енглески
Извор: South African Health Products Regulatory Authority (SAHPRA)
Merckp
NEUROBION® AMPOULES SCHEDULING STATUS: Schedule 1 PROPRIETARY NAME (and dosage form): NEUROBION ® AMPOULES COMPOSITION: Each 3 mL ampoule contains: Vitamin B 1 100 mg Vitamin B 6 100 mg Vitamin B 12 1 mg Benzyl alcohol (preservative) 1% v/v PHARMACOLOGICAL CLASSIFICATION: A.22.1.4 - Vitamins: Others INDICATIONS: NEUROBION Ampoules are indicated where a deficiency of the relevant vitamins exist. CONTRA-INDICATIONS: NEUROBION should not be used in patients on Levodopa therapy. Hypersensitivity to any of the active ingredients. DOSAGE AND DIRECTIONS FOR USE: NEUROBION Ampoules are preferably injected intramuscularly (deep intragluteal). In severe cases 1 ampoule daily until the acute symptoms subside. For milder cases and follow-up therapy 2 or 3 ampoules per week. SIDE-EFFECTS AND SPECIAL PRECAUTIONS: Cyanocobalamin should not be given before a diagnosis has been fully established because of the possibility of masking symptoms of subacute degeneration of the spinal cord. Cyanocobalamin is not a suitable form of Vitamin B 12 for the treatment of optic neuropathies associated with raised plasma concentrations of cyanocobalamin. KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT: Treatment is symptomatic and supportive. IDENTIFICATION: Clear, red solution with no visible particles. PRESENTATION: Boxes of 3 ampoules of 3 mL each. STORAGE INSTRUCTIONS: Keep out of reach of children. Store below 25°C REFERENCE NUMBER: H2488 (Act 101/1965) NAME AND BUSINESS ADDRESS OF THE APPLICANT: Merck (Pty) Ltd. Merck (Pty) Ltd. Reg. No. 70/04059/07 11 Fedlife Park Tonetti Street, Midrand 1685 DATE OF PUBLICATION OF THIS PACKAGE INSERT: 11 March 1988 ® Registered Trade Mark F22306 94C0397 Прочитајте комплетан документ